Net Income

Beyond philanthropy, KinderCare's alumni scholarship is a strategic investment in its brand, building a human capital pipeline from the ground up.

Quantum Computing Inc. is leaving the lab for Las Vegas, betting its US-made photonic chips can solve real-world AI problems and justify a lofty valuation.

Ontario's new FAST program speeds access to cancer drugs like Scemblix, challenging Canada's slow reimbursement system. Is this a new national blueprint?

The space firm secures vital cash through a complex warrant deal, but at what cost to shareholders? All eyes are now on a critical investor vote.

Promising data for NuCana's NUC-7738 offers hope for tough-to-treat melanoma, but the biotech's financial health presents a critical hurdle.

With department stores gone, Primaris REIT is betting on a new model: mixed-use hubs with high-value tenants. Is this the future of Canadian retail?

With new clinical data and recent FDA approval, IceCure Medical's tumor-freezing tech is paving a new, less-invasive path for breast cancer treatment.

Behind EVs, AI, and medical breakthroughs lies a hidden process. Discover how ion implantation shapes the chips that power our future and our trust in it.

A new partnership aims to commercialize Arbli™, the first liquid losartan, leveraging a digital platform to solve patient adherence and capture market share.

Impressive new trial data for MDNA11 could disrupt the multi-billion dollar immunotherapy market, offering real hope where standard treatments now fail.

A CFO's $30k stock purchase is more than a headline. It's part of a pattern of insider confidence at JFB, signaling a bullish outlook.

Early Phase 1 data for VTP-1000 shows promise, but can this novel immunotherapy challenge a crowded market and change life for 80 million patients?

Applegate unites with 11 mission-driven brands in a campaign that redefines partnerships, weaving CSR and consumer engagement into a powerful new strategy.

Beyond a simple payout, Amerigo Resources’ latest dividend reveals a powerful strategy of innovation, financial discipline, and a bullish copper market.

As drone attacks paralyze European airports, an Israeli tech firm's 'soft kill' net system emerges as a key contender for NATO's defense strategy.

With $47.5M and a veteran CEO, PsiThera is using its advanced AI platform to develop oral medicines for diseases long-dominated by injectable biologics.

As holiday travel chaos looms, one luggage brand is offering free bags to travelers with lost luggage. Is it a marketing masterstroke or a logistical nightmare?

Brightstar Lottery's expansion into Pennsylvania with its Cash Pop game and a new $20 price point isn't just a launch—it's a calculated bet on a new player.

Professor Youmin Xi's recent honor signals more than academic success. It marks a strategic blueprint for cultivating the next generation of life science leaders.

A new digital trust framework eliminates paper-based bureaucracy for firms, setting a precedent for frictionless trade and China's Digital Silk Road.